ArticleScientific reports2026
Simultaneous spectrophotometric eco-friendly analysis of triple-drug H.pylori regimen (Vonoprazan, Amoxicillin, Metronidazole) for quality control and in vitro dissolution testing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bacterium Helicobacter pylori is considered a major factor in the pathogenesis of gastric ulcers, gastrointestinal disorders, and gastric cancer, leading to the approval of multiple eradication strategies. Among these is the triple therapy regimen comprising vonoprazan, a potassium-competitive acid blocker, with the antimicrobials amoxicillin and metronidazole. This study introduces Dual-wavelength in ratio spectra, Double Divisor Ratio Spectra Derivative, and Mean Centering of Double Divisor Ratio Spectra methods as advanced spectrophotometric techniques that effectively resolved overlapping spectra of the studied mixture. It is the first instance of using these methodologies to determine the cited mixture. The concentration ranges analyzed were 2–60 µg/mL, 2–32 µg/mL, and 2–25 µg/mL for vonoprazan, amoxicillin, and metronidazole, respectively. Greener non-organic solvent was used to ensure environmental sustainability of analytical methods, significantly reducing ecological and health hazards. Greenness assessment was evaluated using GAPI and AGREE metrics, and blueness was assessed by BAGI. One-way ANOVA comparative assessment revealed no statistically significant differences from the reported method. Validation parameters were evaluated according to ICH guidelines, demonstrating sensitivity and selectivity; therefore, the methods are suitable for routine quality control analysis of the analytes in their ternary mixture and pharmaceutical formulation without prior interference from excipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.